STOCK TITAN

Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin

(Neutral)
(Neutral)
Tags

Allergan Aesthetics (NYSE: ABBV) opened the new Allergan Medical Institute (AMI) Austin on April 7, 2026, its third U.S. AMI Training Center in the past year. The state-of-the-art facility offers immersive, hands-on education across facial injectables, body contouring, skincare, and regenerative medicine to advance clinical proficiency for providers.

AMI Austin emphasizes advanced injection techniques, complication management, practice development, and peer collaboration under Medical Director Dr. Saami Khalifian, supporting the company’s broader training network including Orange County and Atlanta centers.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ABBV

-0.15%
-0.15% Session close to close

In the Apr 7 session, ABBV declined 0.15%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights continued investment in Allergan Aesthetics’ training infrastructure, w...
Analysis

This announcement highlights continued investment in Allergan Aesthetics’ training infrastructure, with AMI Austin becoming the third U.S. AMI center, reinforcing a focus on education, safety, and practice development. Recent history includes promotional initiatives and clinical data releases that support the aesthetics franchise. Investors may watch how expanded training across injectables, body contouring, skincare, and regenerative medicine translates into provider adoption and longer-term demand for the Allergan Aesthetics portfolio.

Key Figures

U.S. AMI centers: 3 centers
1 metrics
U.S. AMI centers 3 centers Third U.S. AMI Training Center opened in the past year

Historical Context

5 past events · Latest: Mar 31 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Mar 31 Promotional campaign Positive +2.0% CoolMonth promotion with discounts and giveaways for CoolSculpting treatments.
Mar 31 Promotion correction Positive +2.0% Corrected details on CoolMonth discounts and Instagram giveaways.
Mar 31 Earnings call notice Neutral +2.0% Announcement of Q1 2026 earnings release and webcast schedule.
Mar 30 Clinical data update Positive +1.8% AAD e-poster data on TrenibotE efficacy, safety, and GLP‑1 patient behavior.
Mar 27 Dermatology evidence Positive -0.8% New clinical and real‑world evidence across immune‑mediated skin diseases.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent Allergan Aesthetics and AbbVie news skew positive, with most items followed by modestly positive price reactions.

Recent Company History

Over late March 2026, AbbVie/Allergan Aesthetics issued several updates spanning promotions, clinical data, and corporate events. On March 27, AbbVie highlighted dermatology evidence and long-term outcomes. On March 30, Allergan Aesthetics shared Phase 3 and real‑world TrenibotE and GLP‑1 patient findings. Multiple CoolSculpting promotions were announced on March 31, alongside notice of the upcoming April 29, 2026 Q1 earnings call. These events typically coincided with small positive moves, framing today’s training-center expansion as part of a continued aesthetics growth narrative.

Key Terms

allergan medical institute, body contouring, regenerative medicine, complication management
4 terms
allergan medical institute medical
"The Allergan Medical Institute (AMI) Austin location strengthens the national"
A medical education and training organization that provides courses, hands-on workshops, and clinical guidance for healthcare professionals on aesthetic procedures and the safe use of related products. For investors, it matters because such an institute helps build practitioner familiarity and confidence with a company’s products—similar to how a demo and training program increases use of a new tool—thereby supporting product adoption, repeat purchases, and brand credibility in the marketplace.
body contouring medical
"including facial injectables, body contouring, skincare, and plastic and"
Body contouring describes surgical or non‑surgical procedures that change the shape or appearance of the body by removing, redistributing or tightening fat and skin—think sculpting a statue to improve proportions. For investors, it signals market demand for devices, treatments and services, potential regulatory approvals, and consumer spending trends that can affect revenues and growth prospects for medical device makers, clinics and cosmetic product companies.
regenerative medicine medical
"skincare, and plastic and regenerative medicine. Participants will gain the"
A field of medical treatments that aims to repair, replace or regenerate damaged tissues and organs using approaches such as cell or gene therapies, engineered tissues, and biologically active materials. It matters to investors because successful regenerative therapies can create entirely new, high-value markets and replace chronic treatments, offering large potential returns but also long development timelines, heavy regulation and high technical risk—like betting on a promising new technology that could either revolutionize care or fail in trials.
complication management medical
"with a focus on advanced injection techniques, complication management, and"
Complication management is the set of protocols, training and resources a healthcare provider or medical product maker uses to prevent, identify and respond to unexpected medical problems that arise during or after treatment. Like a building’s fire drill and emergency exits, it reduces harm to patients and limits extra costs, delays, regulatory scrutiny and legal risk—factors that directly affect a company’s expenses, reputation and potential revenue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
  • The Allergan Medical Institute (AMI) Austin location strengthens the national training network with comprehensive, hands-on education.
  • The Orange County and Atlanta AMI centers continue delivering best-in-class, expert-led aesthetics training focused on improving the treatment experience for patients.

IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced the opening of the new AMI Austin in Texas. This location marks the third U.S. AMI Training Center opened in the past year and reflects continued investment in aesthetics education.

Designed as a state-of-the-art, interactive learning environment, AMI Austin provides an immersive experience that inspires and engages healthcare professionals, advances clinical proficiency for all levels of providers, and creates a welcoming environment for professionals to learn from each other.

AMI Austin brings the same high-impact educational model synonymous with AMI Training Centers, blending scientific rigor with practical application. Through a comprehensive curriculum and hands-on instruction, the center equips providers with clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered outcomes.

"The opening of AMI Austin represents another important milestone in our commitment to elevating aesthetics education standards," said Glen Curran, Senior Vice President, U.S., Allergan Aesthetics. "By expanding into Austin, we're increasing access to robust training that supports excellence in patient care while delivering the education customers need to succeed."

Under the direction of Dr. Saami Khalifian, Double Board-Certified Dermatologist and Medical Director for the AMI Training Centers, the center will offer tailored learning opportunities across experience levels, with a focus on advanced injection techniques, complication management, and practice development. The center provides training across the Allergan Aesthetics portfolio, including facial injectables, body contouring, skincare, and plastic and regenerative medicine. Participants will gain the skills, confidence, and peer connections necessary to accelerate career and practice growth within a collaborative professional community.

As Allergan Aesthetics continues to expand its on-site training footprint, insights from AMI Austin will help inform future AMI innovation. Learnings from real-world programming and provider feedback will guide the evolution of AMI's forward-looking strategy, ensuring future centers are built for scalability, adaptability, and impact with customers.

The new location joins a growing U.S. network that includes AMI Orange County at Allergan Aesthetics headquarters in Irvine, California, and the recently opened AMI Atlanta. For more information on AMI Training Centers, visit trainingcenters.amionline.com.

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

About Allergan Medical Institute (AMI)
Allergan Medical Institute (AMI) is the training arm of Allergan Aesthetics, dedicated to advancing excellence in aesthetics education. AMI provides innovative, high-quality training programs across the Allergan Aesthetics portfolio to empower providers and business owners to elevate patient experiences and outcomes. Learn more at https://us.allerganmedicalinstitute.com.

About AMI Online
AMI Online is a comprehensive, on-demand learning platform offering in-depth education across the Allergan Aesthetics portfolio. Available 24/7, AMI Online supports injectors and practice teams through personalized learning experiences, expert-led content, certification opportunities, and access to upcoming educational events.

Forward-Looking Statements 
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

Contacts:

Allergan Aesthetics Media:
Ember Garrett
Ember.Garrett@allergan.com
+1 (949) 413-6091

AbbVie Investors:
Liz Shea
Liz.Shea@abbvie.com
+1 (847) 935-2211

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-third-state-of-the-art-ami-center-opens-in-austin-302735154.html

SOURCE Allergan Aesthetics, an AbbVie company

FAQ

What did Allergan Aesthetics (ABBV) announce about AMI Austin on April 7, 2026?

Allergan Aesthetics opened a new AMI Training Center in Austin on April 7, 2026. According to the company, AMI Austin is the third U.S. training center opened in the past year and delivers immersive, hands-on education across injectables, body contouring, skincare, and regenerative medicine.

What training programs will AMI Austin offer for healthcare providers (ABBV)?

AMI Austin will offer hands-on programs covering advanced injection techniques and complication management. According to the company, the curriculum also includes practice development, consultative skills, and training across Allergan Aesthetics' product portfolio to boost clinical proficiency and practice growth.

Who will lead the AMI Austin training programs for Allergan Aesthetics (ABBV)?

Dr. Saami Khalifian will direct AMI Austin as Medical Director. According to the company, Dr. Khalifian is a double board-certified dermatologist who will oversee tailored learning across experience levels and ensure clinical rigor in hands-on instruction and complication management.

How does AMI Austin fit into Allergan Aesthetics' U.S. training network (ABBV)?

AMI Austin expands a national network that already includes Orange County and Atlanta centers. According to the company, insights from Austin will inform future AMI innovation and help scale training, adaptability, and program impact across new centers.

How can providers access AMI Training Center information for Allergan Aesthetics (ABBV)?

Providers can find details and program schedules on the AMI Training Centers website. According to the company, trainingcenters.amionline.com lists available courses, locations, and registration information for AMI Austin, Orange County, and Atlanta programs.